Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
As of today (2026-06-24), Kainos Medicine's Intrinsic Value: Projected FCF is ₩-4,026.08. The stock price of Kainos Medicine is ₩1087.00. Therefore, Kainos Medicine's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.
The historical rank and industry rank for Kainos Medicine's Intrinsic Value: Projected FCF or its related term are showing as below:
XKRX:284620's Price-to-Projected-FCF is not ranked *
in the Biotechnology industry.
Industry Median: 1.96 * Ranked among companies with meaningful Price-to-Projected-FCF only.
Kainos Medicine (XKRX:284620) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Kainos Medicine's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
1087.00
/
-4026.0837144337
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kainos Medicine Intrinsic Value: Projected FCF Related Terms
Kainos Medicine Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for Kainos Medicine's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kainos Medicine Intrinsic Value: Projected FCF Chart
XKRX:284620 vs VRTX, REGN, ALNY: Intrinsic Value: Projected FCF Comparison
For the Biotechnology subindustry, Kainos Medicine's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kainos Medicine Price-to-Projected-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kainos Medicine's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Kainos Medicine's Price-to-Projected-FCF falls into.
Kainos Medicine Intrinsic Value: Projected FCF Calculation
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of ₩-4,026.08 mean?
Kainos Medicine (XKRX:284620) has a Intrinsic Value: Projected FCF of ₩-4,026.08 as of Jun. 24, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Kainos Medicine and its competitors.
Is Kainos Medicine's Intrinsic Value: Projected FCF too high?
Kainos Medicine's current Intrinsic Value: Projected FCF is ₩-4,026.08. Overall, Kainos Medicine has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Kainos Medicine's Intrinsic Value: Projected FCF compare to VRTX and REGN?
Kainos Medicine's Intrinsic Value: Projected FCF of ₩-4,026.08 can be compared against companies in the Biotechnology industry. The industry median Intrinsic Value: Projected FCF is 1.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Biotechnology company?
The median Intrinsic Value: Projected FCF among Biotechnology companies is 1.96, based on 257 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Kainos Medicine and its competitors. For the Biotechnology industry, the median Intrinsic Value: Projected FCF is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kainos Medicine's current Intrinsic Value: Projected FCF is ₩-4,026.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kainos Medicine stock overvalued right now?
Kainos Medicine (XKRX:284620) has a current Intrinsic Value: Projected FCF of ₩-4,026.08. The stock's GF Value™ is ₩7,623.81, compared to a current price of ₩1,087.00 — trading 85.7% below its estimated fair value. The current Intrinsic Value: Projected FCF is ₩-4,026.08. Kainos Medicine's overall GF Score™ is 4/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For Kainos Medicine (XKRX:284620), the current Intrinsic Value: Projected FCF is ₩-4,026.08 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kainos Medicine (XKRX:284620) Overvalued in 2026?
Based on GuruFocus' analysis, Kainos Medicine stock appears to be undervalued.
The current stock price of ₩1,087.00 is trading 85.7% below its estimated GF Value™ of ₩7,623.81.
Key valuation signals for XKRX:284620:
Intrinsic Value: Projected FCF: ₩-4,026.08
GF Value™: ₩7,623.81 vs. price of ₩1,087.00 (85.7% below fair value)
No single metric tells the full story. See the XKRX:284620 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:284620 has been successfully added to your 
